PatientsVille.com Logo


Injection Site Haematoma Medical Research Studies

Up-to-date List of Injection Site Haematoma Medical Research Studies

What Research is Being Done?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Following list includes both interventional and observational studies.

Latest Injection Site Haematoma Medical Research Studies

Rank Status Study
1 Unknown  Stem Cell Therapy to Improve the Muscle Function of Patients With Partly Denervated Muscles of the Arm
Condition: Brachial Plexus Injury
Interventions: Procedure: Mononuclear cell injection: 4 * 10e8 cells;   Procedure: Mononuclear cell injection: 8 * 10e8 cells;   Procedure: No mononuclear cell injection
Outcome Measures: To assess muscle improvement, muscle biopsies, quantitative needle EMGs, muscle density analysis, force measurement, range of motion of the elbow joint and quality of life questionnaires will be performed.;   The secondary research aim of this study is to assess vital signs and to detect signs of hematoma and/or injection at the bone marrow aspiration site, injection site and/or surgical wound.
2 Recruiting Landmark Guided Midline Versus Pre-procedural Ultrasound Guided Paramedian at L5S1 for Spinal Anaesthesia
Condition: Anaesthesia
Interventions: Procedure: Conventional landmark guided midline spinal anaesthesia;   Procedure: pre-procedure ultrasound guided L5S1 paramedian spinal;   Device: spinal anaesthesia
Outcome Measures: difference in number of passes between the two groups.;   Number of spinal needle insertion attempts;   Blood in spinal needle;   Time for identifying landmarks;   Time taken for performing spinal anesthetic;   Incidence of radicular pain;   Presence of paresthesia;   Grading of palpated landmarks;   Peri-procedural VAS scores of pain at injection site;   peri-procedural discomfort scores;   Level of block
3 Not yet recruiting Hematoma Block for Reduction of Distal Radius Fractures
Condition: Fractures of the Distal Radius
Interventions: Drug: Lidocaine HCl   2% .;   Drug: Lidocaine  HCl 1%
Outcome Measures: This study will be measured effective in terms of pain relieving with Visual Analog Scale.;   This study will be measured safe in terms of complications to injection.
4 Not yet recruiting Comparison of Two Techniques of Sciatic Nerve Block With Levobupivacaine 0.5% in Orthopedic Surgery
Condition: Anesthesia
Interventions: Procedure: Sciatic nerve anesthesia blockade at bifurcation.;   Procedure: Sciatic nerve blockade 2 cm beyond the bifurcation;   Drug: Levobupivacaine 0.5%: 20 ml;   Device: Portable Ultrasound Machine: Sonosite, M-Turbo, Bothell, WA;   Device: Insulated Needle, (Stimuplex; Braun, Melsungen, Germany);   Drug: supplemental oxygen;   Drug: Midazolam;   Drug: Intravenous analgesics;   Procedure: Saphenous nerve block
Outcome Measures: Latency period of sciatic nerve block.;   Success of sciatic nerve block;   Patient satisfaction;   Sensory block;   Motor block;   First analgesic;   Visual analog scale at rest;   Dynamic visual analog scale;   Intraneural injection;   Vascular puncture;   Paresthesia during the procedure;   Systemic toxicity of local anesthetics;   Hematoma;   Muscle weakness;   Altered sensitivity;   Cramps postoperative;   Punctures;   Time for the execution of nerve block
5 Recruiting PRP vs Corticosteroid in Baker's Cyst
Condition: Baker's Cyst
Interventions: Other: Platelets-Rich-Plasma;   Drug: Corticosteroid
Outcome Measures: Outcome of baker's cysts with the use of Platelets-Rich-Plasma versus Corticosteroid;   Recurrence of baker's cysts treated on each group;   Complications;   Side effects
6 Recruiting Terlipressin Administration in Patients Undergoing Major Liver Resection
Conditions: Liver Resection;   Liver Failure
Interventions: Drug: Terlipressin;   Drug: Placebo
Outcome Measures: Number of patients with incident of a composite end point;   Number of patients with pleural effusion;   Number of patients with surgical site infection;   Number of patients with sepsis;   Number of patients with pneumonia;   Number of patients with intraabdominal hematoma;   Number of patients with acute renal failure;   Number of patients with blood transfusion

These studies may lead to new treatments and are adding insight into Injection Site Haematoma etiology and treatment.

A major focus of Injection Site Haematoma research is the development of new drugs and other treatment options. Studies seek to identify new drugs to treat various related disorders and to find safer, more effective doses for medications already being used. Other research is aimed at identifying receptors or drug targets.

Discuss Injection Site Haematoma